Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT00179660 · COMPLETED

Trial details

NCT number: NCT00179660
Sponsor: Celgene Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkins Lymphoma

Start date: 2005-08-01
Primary completion: 2008-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.